Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1 , were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5′ untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1 . Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The high expression levels of ERG and PEA3 subfamily members in a subset of prostate tumors led to the discovery of common chromosomal rearrangements associated with this human cancer (36).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [36]
In the citing paper
“Chromosomal rearrangements that result in the overexpression of members of the PEA3 subfamily (ETV1, ETV4, or ETV5) are found less frequently (36, 170, 171).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [36]
In the citing paper
“Rearrangements of ETS loci are a hallmark of prostate cancer with ~50% of tumors showing alterations at an ETS gene locus (36).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [36]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
Self-citationA census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Self-citationChromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R. (1982) · Nature · doi:10.1038/300765a0 · Cited by 1,378
Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia
Valk, P. J. M., Verhaak, R. G. W., Beijen, M. A., Erpelinck, C. A. J., van Doorn-Khosrovani, S. B. V. W., Boer, J. M., Beverloo, H. B., Moorhouse, M. J., van der Spek, P. J., Löwenberg, B., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040465 · Cited by 1,370
Research works printed but not linked: 5
- I. S. Jeon et al., Oncogene10, 1229 (1995).
- B. Lin et al., Cancer Res.59, 4180 (1999).
- D. E. Afar et al., Cancer Res.61, 1686 (2001).
- S. M. Dhanasekaran et al., FASEB J.19, 243 (2005).
- J. B. Welsh et al., Cancer Res.61, 5974 (2001).
Cited by
Items 301–400 of 1,014
Danila, D. C., Anand, A., Sung, C. C., Heller, G., Leversha, M. A., Cao, L., Lilja, H., Molina, A., Sawyers, C. L., Fleisher, M., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.07.011 · Cited by 192
Yang, M., Kozminski, D. J., Wold, L. A., Modak, R., Calhoun, J. D., Isom, L. L., & Brackenbury, W. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2102-9 · Cited by 184
Epithelial-mesenchymal transition in prostate cancer: an overview
Montanari, M., Rossetti, S., Cavaliere, C., D’Aniello, C., Malzone, M. G., Vanacore, D., Franco, R. D., Mantia, E. L., Iovane, G., Piscitelli, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15686 · Cited by 180
Membrane-Anchored Serine Proteases in Health and Disease
Antalis, T. M., Bugge, T. H., & Wu, Q. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385504-6.00001-4 · Cited by 188
Nickols, N. G., & Dervan, P. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704217104 · Cited by 189
Teschendorff, A. E., Jones, A., Fiegl, H., Sargent, A., Zhuang, J. J., Kitchener, H. C., & Widschwendter, M. (2012) · Genome Medicine · doi:10.1186/gm323 · Cited by 182
Kron, K. J., Murison, A., Zhou, S., Huang, V., Yamaguchi, T. N., Shiah, Y.-J., Fraser, M., van der Kwast, T., Boutros, P. C., Bristow, R. G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3930 · Cited by 187
Integrated genomic profiling expands clinical options for patients with cancer
Beaubier, N., Bontrager, M., Huether, R., Igartua, C., Lau, D., Tell, R., Bobe, A. M., Bush, S., Chang, A. L., Hoskinson, D. C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0259-z · Cited by 187
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Attard, G., Richards, J., & de Bono, J. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0567 · Cited by 183
Molecular markers of prostate cancer outcome
Quinn, D. I., Henshall, S. M., & Sutherland, R. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.035 · Cited by 191
Chromosomal translocations in cancer
Nambiar, M., Kari, V., & Raghavan, S. C. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.07.005 · Cited by 180
Chromatin structural elements and chromosomal translocations in leukemia
Zhang, Y., & Rowley, J. D. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.020 · Cited by 182
Arredouani, M. S., Lu, B., Bhasin, M., Eljanne, M., Yue, W., Mosquera, J.-M., Bubley, G. J., Li, V., Rubin, M. A., Libermann, T. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0911 · Cited by 184
Self-citationGENT: Gene Expression Database of Normal and Tumor Tissues
Shin, G., Kang, T.-W., Yang, S., Baek, S.-J., Jeong, Y.-S., & Kim, S.-Y. (2011) · Cancer Informatics · doi:10.4137/cin.s7226 · Cited by 188
Recurrent read-through fusion transcripts in breast cancer
Varley, K. E., Gertz, J., Roberts, B. S., Davis, N. S., Bowling, K. M., Kirby, M. K., Nesmith, A. S., Oliver, P. G., Grizzle, W. E., Forero, A., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3019-2 · Cited by 181
Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer
Wyce, A., Degenhardt, Y., Bai, Y., Le, B., Korenchuk, S., Crouthamel, M.-C., McHugh, C. F., Vessella, R., Creasy, C. L., Tummino, P. J., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1572 · Cited by 179
Topoisomerase-mediated chromosomal break repair: an emerging player in many games
Ashour, M. E., Atteya, R., & El-Khamisy, S. F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3892 · Cited by 180
Klein, E. A., Yousefi, K., Haddad, Z., Choeurng, V., Buerki, C., Stephenson, A. J., Li, J., Kattan, M. W., Magi-Galluzzi, C., & Davicioni, E. (2015) · European Urology · doi:10.1016/j.eururo.2014.10.036 · Cited by 186
Welsbie, D. S., Xu, J., Chen, Y., Borsu, L., Scher, H. I., Rosen, N., & Sawyers, C. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2216 · Cited by 182
ALKoma: A Cancer Subtype with a Shared Target
Mano, H. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0009 · Cited by 182
“EML4-ALK was the fi rst recurrent fusion-type oncogene in NSCLC, and, together with ETS fusions in prostate cancer (25), its existence argues against the previous notion that oncogenesis mediated by chromosome rearrangement is relatively specifi c to hematologic malignancies and sarcomas (rather than epithelial tumors…”
BackgroundYoshimoto, M., Cutz, J.-C., Nuin, P. A. S., Joshua, A. M., Bayani, J., Evans, A. J., Zielenska, M., & Squire, J. A. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.04.003 · Cited by 181
Yoshimoto, M., Joshua, A. M., Chilton-MacNeill, S., Bayani, J., Selvarajah, S., Evans, A. J., Zielenska, M., & Squire, J. A. (2006) · Neoplasia · doi:10.1593/neo.06283 · Cited by 185
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
Goodwin, J. F., Kothari, V., Drake, J. M., Zhao, S., Dylgjeri, E., Dean, J. L., Schiewer, M. J., McNair, C., Jones, J. K., Aytes, A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.06.004 · Cited by 180
Self-citationStem cells in prostate cancer initiation and progression
Lawson, D. A., & Witte, O. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32810 · Cited by 179
Inhibiting TRK Proteins in Clinical Cancer Therapy
Lange, A., & Lo, H.-W. (2018) · Cancers · doi:10.3390/cancers10040105 · Cited by 175
FitzGerald, L. M., Agalliu, I., Johnson, K., Miller, M. A., Kwon, E. M., Hurtado-Coll, A., Fazli, L., Rajput, A. B., Gleave, M. E., Cox, M. E., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-230 · Cited by 177
Targeting the Androgen Signaling Axis in Prostate Cancer
Dai, C. S., Dehm, S. M., & Sharifi, N. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00433 · Cited by 194
Genomic rearrangements in inherited disease and cancer
Chen, J.-M., Cooper, D. N., Férec, C., Kehrer-Sawatzki, H., & Patrinos, G. P. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.05.007 · Cited by 177
Baena, E., Shao, Z., Linn, D. E., Glass, K., Hamblen, M. J., Fujiwara, Y., Kim, J., Nguyen, M., Zhang, X., Godinho, F. J., et al. (2013) · Genes & Development · doi:10.1101/gad.211011.112 · Cited by 175
“Chromosomal rearrangements involving genes encoding ETS transcription factors (notably, ERG and ETV1) are found in;50% of human prostate cancer cases and likely constitute the most frequent gene rearrangements in human malignancies (Tomlins et al. 2005; Gopalan et al. 2009).”
BackgroundGibbs, A., Schwartzman, J., Deng, V., & Alumkal, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908908106 · Cited by 172
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Wang, J., Cai, Y., Yu, W., Ren, C., Spencer, D. M., & Ittmann, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1147 · Cited by 173
The central role of EED in the orchestration of polycomb group complexes
Cao, Q., Wang, X., Zhao, M., Yang, R., Malik, R., Qiao, Y., Poliakov, A., Yocum, A. K., Li, Y., Chen, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms4127 · Cited by 164
Self-citationTargeting Continued Androgen Receptor Signaling in Prostate Cancer
Massard, C., & Fizazi, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2815 · Cited by 178
Rajput, A. B., Miller, M. A., De Luca, A., Boyd, N., Leung, S., Hurtado-Coll, A., Fazli, L., Jones, E. C., Palmer, J. B., Gleave, M. E., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.043810 · Cited by 175
Nakagawa, T., Kollmeyer, T. M., Morlan, B. W., Anderson, S. K., Bergstralh, E. J., Davis, B. J., Asmann, Y. W., Klee, G. G., Ballman, K. V., & Jenkins, R. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002318 · Cited by 179
Rhodes, D. R., Ateeq, B., Cao, Q., Tomlins, S. A., Mehra, R., Laxman, B., Kalyana-Sundaram, S., Lonigro, R. J., Helgeson, B. E., Bhojani, M. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900351106 · Cited by 172
Self-citationRecurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing
Kannan, K., Wang, L., Wang, J., Ittmann, M. M., Li, W., & Yen, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100489108 · Cited by 181
Chen, Y.-W., Lee, M.-S., Lucht, A., Chou, F.-P., Huang, W., Havighurst, T. C., Kim, K., Wang, J.-K., Antalis, T. M., Johnson, M. D., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090665 · Cited by 174
Zhang, Y., Gong, M., Yuan, H., Park, H. G., Frierson, H. F., & Li, H. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0042 · Cited by 176
Maintaining and reprogramming genomic androgen receptor activity in prostate cancer
Mills, I. G. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3678 · Cited by 172
Cieslik, M., Chugh, R., Wu, Y.-M., Wu, M., Brennan, C., Lonigro, R., Su, F., Wang, R., Siddiqui, J., Mehra, R., et al. (2015) · Genome Research · doi:10.1101/gr.189621.115 · Cited by 177
“Next, we assessed whether the differences in splice junction coverage actually influenced our ability to detect TMPRSS2-ERG, a known gene fusion (Tomlins et al. 2005).”
BackgroundSelf-citationPrevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort
Esgueva, R., Perner, S., J LaFargue, C., Scheble, V., Stephan, C., Lein, M., Fritzsche, F. R., Dietel, M., Kristiansen, G., & Rubin, M. A. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.193 · Cited by 173
Self-citationAR Signaling and the PI3K Pathway in Prostate Cancer
Crumbaker, M., Khoja, L., & Joshua, A. (2017) · Cancers · doi:10.3390/cancers9040034 · Cited by 162
Outlier sums for differential gene expression analysis
Tibshirani, R., & Hastie, T. (2007) · Biostatistics · doi:10.1093/biostatistics/kxl005 · Cited by 174
“We also compare our approach to the recent COPA proposal of Tomlins et al. (2005).”
ResultUrinary biomarkers of prostate cancer
Fujita, K., & Nonomura, N. (2018) · International Journal of Urology · doi:10.1111/iju.13734 · Cited by 172
Transcription Factors in Cancer Development and Therapy
Vishnoi, K., Viswakarma, N., Rana, A., & Rana, B. (2020) · Cancers · doi:10.3390/cancers12082296 · Cited by 164
“ETS TFs are considered as major oncodrivers, linking family members FL1 in Ewing sarcoma, ETS in leukemia [100], and ERG gene fusion in prostate cancer [101].”
BackgroundLightbody, G., Haberland, V., Browne, F., Taggart, L., Zheng, H., Parkes, E., & Blayney, J. K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby051 · Cited by 173
“Fusion genes, when two individual genes form a hybrid gene, can also be associated with disease development, as with TMPRSS2-ERG in prostate cancer [29].”
BackgroundAgoulnik, I. U., Vaid, A., Nakka, M., Alvarado, M., Bingman, W. E., Erdem, H., Frolov, A., Smith, C. L., Ayala, G. E., Ittmann, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1023 · Cited by 168
Tu, J. J., Rohan, S., Kao, J., Kitabayashi, N., Mathew, S., & Chen, Y.-T. (2007) · Modern Pathology · doi:10.1038/modpathol.3800903 · Cited by 170
Androgen regulation of micro‐RNAs in prostate cancer
Waltering, K. K., Porkka, K. P., Jalava, S. E., Urbanucci, A., Kohonen, P. J., Latonen, L. M., Kallioniemi, O. P., Jenster, G., & Visakorpi, T. (2011) · The Prostate · doi:10.1002/pros.21276 · Cited by 166
Attard, G., Reid, A. H. M., Olmos, D., & de Bono, J. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4531 · Cited by 168
Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
Qiao, Y., Wang, X.-M., Mannan, R., Pitchiaya, S., Zhang, Y., Wotring, J. W., Xiao, L., Robinson, D. R., Wu, Y.-M., Tien, J. C.-Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021450118 · Cited by 164
“Oncogenic androgen-regulated TMPRSS2ETS gene fusions are also found in upward of 50% of prostate cancers (8, 9).”
BackgroundSelf-citationBiomarkers in prostate cancer – Current clinical utility and future perspectives
Kretschmer, A., & Tilki, D. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.007 · Cited by 167
Liu, S., Tsai, W.-H., Ding, Y., Chen, R., Fang, Z., Huo, Z., Kim, S., Ma, T., Chang, T.-Y., Priedigkeit, N. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1234 · Cited by 162
Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins
Lindberg, J., Klevebring, D., Liu, W., Neiman, M., Xu, J., Wiklund, P., Wiklund, F., Mills, I. G., Egevad, L., & Grönberg, H. (2013) · European Urology · doi:10.1016/j.eururo.2012.03.050 · Cited by 163
“Although we did not investigate rearrangements, which are commonly found in PCa [8], we provide three lines of evidence in support of our conclusions.”
BackgroundResultNacu, S., Yuan, W., Kan, Z., Bhatt, D., Rivers, C. S., Stinson, J., Peters, B. A., Modrusan, Z., Jung, K., Seshagiri, S., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-11 · Cited by 167
An Extensive Network of TET2-Targeting MicroRNAs Regulates Malignant Hematopoiesis
Cheng, J., Guo, S., Chen, S., Mastriano, S. J., Liu, C., D’Alessio, A. C., Hysolli, E., Guo, Y., Yao, H., Megyola, C. M., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.050 · Cited by 160
Shinmura, K., Kageyama, S., Tao, H., Bunai, T., Suzuki, M., Kamo, T., Takamochi, K., Suzuki, K., Tanahashi, M., Niwa, H., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.12.013 · Cited by 164
Komura, K., Jeong, S. H., Hinohara, K., Qu, F., Wang, X., Hiraki, M., Azuma, H., Lee, G.-S. M., Kantoff, P. W., & Sweeney, C. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600420113 · Cited by 164
The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer
Mollica, V., Rizzo, A., & Massari, F. (2020) · Future Oncology · doi:10.2217/fon-2020-0571 · Cited by 163
“In particular, the TMPRSS2:v-ets avian erythroblastosis virus E26 oncogene homolog (ERG) gene fusion is present in about 50% of prostate tumors in Caucasian men and is frequently an early event in prostate carcinogenesis [5,6].”
BackgroundEvidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
Khani, F., Mosquera, J. M., Park, K., Blattner, M., O'Reilly, C., MacDonald, T. Y., Chen, Z., Srivastava, A., Tewari, A. K., Barbieri, C. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2265 · Cited by 164
Self-citationIntegrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
Horak, P., Fröhling, S., & Glimm, H. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000094 · Cited by 179
Veeraraghavan, J., Tan, Y., Cao, X.-X., Kim, J. A., Wang, X., Chamness, G. C., Maiti, S. N., Cooper, L. J. N., Edwards, D. P., Contreras, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5577 · Cited by 176
Self-citationThe importance of DNA methylation in prostate cancer development
Massie, C. E., Mills, I. G., & Lynch, A. G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.009 · Cited by 173
SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts
Blattner, M., Lee, D. J., O'Reilly, C., Park, K., MacDonald, T. Y., Khani, F., Turner, K. R., Chiu, Y.-L., Wild, P. J., Dolgalev, I., et al. (2014) · Neoplasia · doi:10.1593/neo.131704 · Cited by 159
Self-citationThompson, S. L., & Compton, D. A. (2010) · Chromosome Research · doi:10.1007/s10577-010-9179-y · Cited by 183
Gozdecka, M., Meduri, E., Mazan, M., Tzelepis, K., Dudek, M., Knights, A. J., Pardo, M., Yu, L., Choudhary, J. S., Metzakopian, E., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0114-z · Cited by 162
A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
Kohaar, I., Petrovics, G., & Srivastava, S. K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081813 · Cited by 174
“The oncogenic activation of ERG by these gene fusions is detected in 50% to 65% of prostate cancer patients of European ancestry [60,78].”
BackgroundOncogene-specific activation of tyrosine kinase networks during prostate cancer progression
Drake, J. M., Graham, N. A., Stoyanova, T., Sedghi, A., Goldstein, A. S., Cai, H., Smith, D. A., Zhang, H., Komisopoulou, E., Huang, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120985109 · Cited by 159
Risk factors for prostate cancer
Patel, A. R., & Klein, E. A. (2009) · Nature Clinical Practice Urology · doi:10.1038/ncpuro1290 · Cited by 222
The molecular and cellular origin of human prostate cancer
Packer, J. R., & Maitland, N. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.016 · Cited by 241
High‐resolution genomic and expression analyses of copy number alterations in breast tumors
Haverty, P. M., Fridlyand, J., Li, L., Getz, G., Beroukhim, R., Lohr, S., Wu, T. D., Cavet, G., Zhang, Z., & Chant, J. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20558 · Cited by 158
Therapeutic Targeting of SPINK1-Positive Prostate Cancer
Ateeq, B., Tomlins, S. A., Laxman, B., Asangani, I. A., Cao, Q., Cao, X., Li, Y., Wang, X., Feng, F. Y., Pienta, K. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001498 · Cited by 160
Self-citationClappier, E., Mf, A., Rapion, J., Bakkus, M. H. C., Caye‐Eude, A., Khemiri, A., Giroux, C., Hernandez, L., Kabongo, E., Savola, S. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.277 · Cited by 162
Ulz, P., Belic, J., Graf, R., Auer, M., Lafer, I., Fischereder, K., Webersinke, G., Pummer, K., Augustin, H., Pichler, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12008 · Cited by 163
Ko, C., Huang, C.-C., Lin, H.-Y., Juan, C.-P., Lan, S., Shyu, H., Wu, S., Hsiao, P., Huang, H., Shun, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3297 · Cited by 159
Dhanasekaran, S. M., Alejandro Balbin, O., Chen, G., Nadal, E., Kalyana-Sundaram, S., Pan, J., Veeneman, B., Cao, X., Malik, R., Vats, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6893 · Cited by 155
Self-citationFusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Sboner, A., Habegger, L., Pflueger, D., Terry, S., Chen, D. Z., Rozowsky, J. S., Tewari, A. K., Kitabayashi, N., Moss, B. J., Chee, M. S., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r104 · Cited by 159
Self-citationA transcriptional repressor co‐regulatory network governing androgen response in prostate cancers
Chng, K. R., Chang, C. W., Tan, S. K., Yang, C., Hong, S. Z., Sng, N. Y. W., & Cheung, E. C. W. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.112 · Cited by 167
Sanda, M. G., Feng, Z., Howard, D. H., Tomlins, S. A., Sokoll, L. J., Chan, D. W., Regan, M. M., Groskopf, J., Chipman, J., Patil, D. H., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0177 · Cited by 158
Self-citationOncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Hollenhorst, P. C., Ferris, M. W., Hull, M. A., Chae, H., Kim, S., & Graves, B. J. (2011) · Genes & Development · doi:10.1101/gad.17546311 · Cited by 154
Lotan, T. L., Gümüşkaya, B., Rahimi, H. A., Hicks, J. L., Iwata, T., Robinson, B. D., Epstein, J. I., & Marzo, A. M. D. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.201 · Cited by 161
Mao, X., Yu, Y., Boyd, L. K., Ren, G., Lin, D., Chaplin, T., Kudahetti, S. C., Stankiewicz, E., Xue, L., Beltrán, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4074 · Cited by 157
Shah, A. V., Birdsey, G. M., & RANDI, A. M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.003 · Cited by 168
Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
Sardana, G., Dowell, B. L., & Diamandis, E. P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.110668 · Cited by 156
TMPRSS2-ERG Fusion Heterogeneity in Multifocal Prostate Cancer: Clinical and Biologic Implications
Barry, M., Perner, S., Demichelis, F., & Rubin, M. A. (2007) · Urology · doi:10.1016/j.urology.2007.08.032 · Cited by 156
Self-citationLandscape of gene fusions in epithelial cancers: seq and ye shall find
Kumar‐Sinha, C., Sundaram, S. K., & Chinnaiyan, A. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0252-1 · Cited by 165
Self-citationHan, B., Mehra, R., Dhanasekaran, S. M., Yu, J., Menon, A., Lonigro, R. J., Wang, X., Gong, Y., Wang, L., Shankar, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2014 · Cited by 154
Self-citationIntegrative epigenetic taxonomy of primary prostate cancer
Stelloo, S., Nevedomskaya, E., Kim, Y., Schuurman, K., Valle-Encinas, E., Lobo, J., Krijgsman, O., Peeper, D. S., Chang, S. L., Feng, F. Y.-C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07270-2 · Cited by 154
An, J., Ren, S., Murphy, S. J., Dalangood, S., Chang, C., Pang, X., Cui, Y., Wang, L., Pan, Y., Zhang, X., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.025 · Cited by 163
How does DNA break during chromosomal translocations?
Nambiar, M., & Raghavan, S. C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr223 · Cited by 167
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
Clark, J., Attard, G., Jhavar, S. G., Flohr, P., Reid, A. H. M., Bono, J. S. D., Eeles, R. A., Scardino, P. T., Cuzick, J. M., Fisher, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210843 · Cited by 165
Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences
Mani, R. S., & Chinnaiyan, A. M. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2883 · Cited by 171
Self-citationTang, Y., Pan, J., Huang, S., Peng, X., Zou, X., Luo, Y., Ren, D., Zhang, X., Li, R., He, P., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0813-4 · Cited by 159
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer
Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac129 · Cited by 152
Cai, C., Wang, H., Xu, Y., Chen, S., & Balk, S. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0395 · Cited by 151
Chaux, A., Albadine, R., Toubaji, A., Hicks, J. L., Meeker, A. K., Platz, E. A., Marzo, A. M. D., & Netto, G. J. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31821e8761 · Cited by 151
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 169
Wang, S., Li, H., Song, M., He, Z., Wu, T., Wang, X., Tao, Z., Wu, K., & Liu, X. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009557 · Cited by 163
Mortensen, M. M., Høyer, S., Lynnerup, A.-S., Orntoft, T. F., Sørensen, K. D., Borre, M., & Dyrskjøt, L. (2015) · Scientific Reports · doi:10.1038/srep16018 · Cited by 152
Metadata
- Authors
- Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M.
- Affiliations
- University of Michigan (US)
- Department of Pathology, University of Michigan Medical School, 1301 Catherine Street, Ann Arbor, MI 48109–0602, USA.
- Corresponding author
- Chinnaiyan, Arul M.
- ORCID
- Venue
- Science
- Published
- 2005-10-28
- Volume
- 310
- Issue
- 5748
- Pages
- 644-648
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121158863
- Cited by
- 3,846
- References
- 32
- Citations by year
- 2026: 77 · 2025: 99 · 2024: 82 · 2023: 108 · 2022: 137 · 2021: 163 · 2020: 187 · 2019: 172 · 2018: 178 · 2017: 218 · 2016: 209 · 2015: 244 · 2014: 271 · 2013: 309 · 2012: 279
- FWCI
- 114.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG021404, R01 AG 21404)
- National Cancer Institute (UO1 CA111275-01, P50-CA-69568, U01CA111275, R01CA097063, R01 CA97063, 5P30 CA 46592, P50CA069568, P30CA046592)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Keywords
- TMPRSS2-ERG fusion, prostate cancer, ETS transcription factors, chromosomal rearrangements, gene fusion, molecular diagnosis
- MeSH terms
- Transcriptional Regulator ERG, Androgens, DNA-Binding Proteins, Humans, Male, Membrane Proteins, Molecular Sequence Data, Neoplasm Proteins, Prostatic Neoplasms, Serine Endopeptidases, Transcription Factors, Translocation, Genetic, Gene Rearrangement, Oncogene Proteins, Fusion, Trans-Activators, Gene Expression Regulation, Neoplastic, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.